Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: A LIFE substudy

Journal of Human Hypertension

Volumn 18, Issue 6, 2004, Pages 453-459

  Olsen, M H ^a   Wachtell, K ^a   Bella, J N ^b   Palmieri, V ^b   Gerdts, E ^c   Smith, G ^d   Nienimen, M S ^e   Dahlof B ^f   Ibsen, H ^a   Devereux, R B ^b  

^a Dept of Clin Physiol/Nuclear Med   (Denmark)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albuminuria; Cardiovascular events; Hypertension; Left ventricular hypertrophy; Prognosis

Indexed keywords

ALBUMIN; ATENOLOL; CREATININE; LOSARTAN; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL DOCUMENTATION; OUTCOMES RESEARCH; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROTEIN URINE LEVEL; PROTEINURIA; RISK ASSESSMENT; SCORING SYSTEM; STROKE;

AGED; AGED, 80 AND OVER; ALBUMINURIA; CEREBROVASCULAR ACCIDENT; CREATININE; DEATH, SUDDEN, CARDIAC; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS;

EID: 2942702168     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001711     Document Type: Article

References (32)

1. Liao Y et al, Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 648-650, (see comments).
2. Borch-Johnsen K et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.
3. Wachtell K et al. Are urinary albumin excretion and left ventricular hypertrophy both independent predictors of overall mortality in patients with electrocardiographic left ventricular hypertrophy? J Am Coll Cardiol 2002; 39: 237A.
4. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995; 112: 245-252.
5. Cirillo M et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 1998; 158: 1933-1939.
6. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch) 1995; 88: 629-633.
7. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1324-1329.
8. Olsen MH et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530-537.
9. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study (in process citation). Hypertension 1998; 32: 989-997.
10. Wachtell K et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35(1 Part 1): 6-12.
11. Devereux RB et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Blood Press 2001; 10: 74-82.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
13. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
14. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement (see comments). J Am Coll Cardiol 1999; 34: 1625-1632.
15. Wachtell K et al. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint. Am J Cardiol 2001;87:54-60.
16. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990; 120: 116-123.
17. de Simone G et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension 1997; 29: 1213-1217.
18. de Simone G et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444-1451.
19. Devereux RB et al. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31: 929-936.
20. Roman MJ et al. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25: 83-90.
21. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990; 27(Part 4): 297-312.
22. Irgens-Moller L, Hemmingsen L, Holm J. Diagnostic value of microalbuminuria in pre-eclampsia. Clin Chim Acta 1986; 157: 295-298.
23. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen BF, Jensen G. Screening of microalbuminuria with the Micral-test. A semi-quantitative urinary dipstick. Ugeskr Laeger 1993; 155: 4155-4157.
24. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993; 306: 1722-1725.
25. Feldt-Rasmussen B et al. Microalbuminuria: an important diagnostic tool. J Diabetes Complic 1994; 8: 137-145.
26. Jensen JS et al. Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria. Eur J Clin Invest 1995; 25: 608-614.
27. Jensen JS et al. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997; 11: 727-732, (see comments).
28. Olsen MH et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530-537.
29. Roman MJ et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-1918.
30. Jones EC et al. Relation of hemodynamic volume load to arterial and cardiac size. J Am Coll Cardiol 1997; 29: 1303-1310.
31. Vogt M, Motz W, Scheler S, Strauer BE. Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990; 65: 45G-50G.
32. Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.